Innovative strategy for improving the oral delivery of amphotericin b: design, development and evaluation of functional hydrophobic prodrugs
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: THANKI, Kaushik (National Institute of Pharmaceutical Education and Research (NIPER), Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, Mohali, India)
- Co-author(s): Jain, Sanyog (National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India)
Background The clinical utility of potent therapeutic agent, Amphotericin B (AmB) is often restricted due to hemolytic toxicity and nephrotoxicity, even leading to early termination of therapy. It is available only as injection only product posing pharmacoeconomic complications and poor patient compliance
Aim The work focusses on design,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.